Batch-based BRCA1/BRCA2 variant reclassification

Batch-based BRCA1/BRCA2 variant reclassification improves cost-effectiveness in silico.

In silicoper 1000 30-year-old women with prior BRCA1/2 testingfemalesn = 1,000

Cost-effectiveness of BRCA1/BRCA2 variant reclassification and recontact for hereditary breast and ovarian cancer in the United States

Genetics in medicine : official journal of the American College of Medical Genetics·26 Aug 2026